A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow–Derived Progenitor Cell Infusion in Patients With Nonischemic Dilated Cardiomyopathy-Reference-Cited by-同舟云学术

A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow–Derived Progenitor Cell Infusion in Patients With Nonischemic Dilated Cardiomyopathy

Published:2009-09 Issue:5 Volume:2 Page:417-423
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ Heart Fail

Author:

Fischer-Rasokat Ulrich¹,Assmus Birgit¹,Seeger Florian H.¹,Honold Jörg¹,Leistner David¹,Fichtlscherer Stephan¹,Schächinger Volker¹,Tonn Torsten¹,Martin Hans¹,Dimmeler Stefanie¹,Zeiher Andreas M.¹

Affiliation:

1. From the Cardiology and Molecular Cardiology (U.F.-R., B.A., F.H.S., J.H., D.L., S.F., V.S., S.D., A.M.Z.), Department of Medicine III, Goethe University of Frankfurt, Frankfurt/Main, Germany; Institute for Transfusion Medicine and Immunohematology (T.T.), Red Cross Blood Donor Service Baden-Württemberg-Hessen, Frankfurt/Main, Germany; and Institute of Hematology (H.M.), Department of Medicine II, Goethe University of Frankfurt, Frankfurt/Main, Germany.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy

2. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure

3. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal STRO-1/STRO-3⁺ precursor cells for the treatment of chronic heart failure with reduced ejection fraction;Future Cardiology;2023-11-07

2. DCM Support: cell therapy and circulatory support for dilated cardiomyopathy patients with severe ventricular impairment;ESC Heart Failure;2023-05-15

3. Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?;Biomedicines;2023-02-11

4. Entwicklung von Stammzellen in der kardio-regenerativen Therapie;Stammzellen;2023

5. Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure;Journal of Cardiovascular Development and Disease;2022-12-01